Published by
@ShahidNShah
@ShahidNShah
November 29, 2022
Online
It’s no secret that the COVID-19 pandemic drove a rapid increase in the adoption of decentralized clinical trials (DCTs) across the life sciences industry. Utilizing digital technologies has demonstrated ample benefits to sponsors, study teams and importantly, patients. These benefits include increasing efficiency across clinical operations and data management, simplifying the sponsor technology ecosystem, reducing patient and site burden, accelerating timelines, providing access to real-time data and insights, improving access to more diverse patient populations and more.
Continue reading at xtalks.com
November 29 to November 30, 2022
Bangkok, Thailand
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 21, 2024 at 12:56pm